Our annual retreat was a wonderful success thanks to all of the members who attended on Monday. I am especially grateful to the 18 presenters who gave excellent summaries of the exciting research currently underway in Yale Cancer Center laboratories. Each of our shared resource leaders also presented posters from their cores. Their work illustrates the huge impact these services make on successful research projects at Yale Cancer Center.
Michael Seiden, MD, PhD, President and CEO of Fox Chase Cancer Center presented his vision for Building and Stewarding Cancer Centers during the keynote address. His insights and valuable advice will be helpful to all of us as we continue to strengthen Yale Cancer Center and Smilow Cancer Hospital at Yale-New Haven in the coming years. For those of you who have asked, here is a link to the video segment he shared, "Did You Know?".
Cancer Survivors Day
Yale Cancer Center and Smilow Cancer Hospital at Yale-New Haven will celebrate Cancer Survivors Day with our patients and their families on Wednesday, May 26th at Yale's West Campus. The evening will begin with a session in the auditorium, followed by a picnic supper and entertainment. Please encourage your patients to attend with their families. I hope to see many of the clinicians and caregivers in attendance as well.
Read all the latest news, featuring members and clinicians from Yale Cancer Center and Smilow Cancer Hospital at Yale-New Haven, online.
Read More >>
Nina Kadan-Lottick, MD
recently received a Research Scholar Grant in Cancer Control for $600,000 from the
American Cancer Society
. The grant will compare two models of cancer survivorship care. One model will be delivered by primary care physicians and the second will be provided by specialty survivorship clinics. The study will include approximately 350 patients identified through the Yale Cancer Center Rapid Case Ascertainment Shared Resource, in collaboration with the Connecticut Tumor Registry.
Cary Gross, MD
Xiaomei Ma, PhD
are co-collaborators on the project.
AACR's Annual Scientific Awards
The AACR is now accepting nominations for the following awards recognizing excellence in cancer research:
AACR Outstanding Investigator Award for Breast Cancer Research
, funded by Susan G. Komen for the Cure® for an investigator whose novel and significant work has had or may have a far-reaching impact on the etiology, detection, diagnosis, treatment, or prevention of breast cancer.
Nomination Deadline: May 20, 2010
Learn More >>
AACR-Prevent Cancer Foundation Award for Excellence in Cancer Prevention Research
for a scientist for his or her seminal contributions to the field of cancer prevention which have had a major impact on the field and stimulated new directions in this important area.
Breast Cancer Alliance (BCA) Young Investigator Grant
To encourage a commitment to breast cancer research, the Breast Cancer Alliance invites clinical doctors and research scientists who have been appointed to a position equivalent to Assistant Professor within three years of the appointment, and whose primary focus is breast cancer research, to apply for funding for the Young Investigator Grant.
The term of the Young Investigator Grant is two years. The grant provides salary support and project costs of $125,000 over two years. The $125,000 award includes administrative costs, which must be limited to 8% of the grant funds.
The research project must be directly related to the field of breast cancer. Areas of relevant research may include but are not limited to: diagnosis, etiology, immunology, genetics, therapies, prevention, and clinical studies.
The Cancer Prevention and Control Research Program strives to conduct cutting-edge research to identify the causes of human cancers, and then use behavioral and other approaches to translate these findings into public health interventions to reduce cancer incidence, cancer morbidity, and mortality.
The program is organized into two themes:
1. To elucidate the role of lifestyle factors and genetics in the etiology of cancer.
Nutrition, physical activity, obesity and cancer
Environmental factors and cancer
Molecular/genetic factors in cancer
Racial disparities in cancer
Cancer biostatistics methods research
2. To evaluate behavioral interventions for cancer prevention and control.
Cancer prevention/early detection behaviors
Secondary prevention interventions in cancer survivors
Symptom control/quality of life in cancer patients
Palliative and end-of-life care for cancer patients
There are currently 32 members of the Cancer Prevention and Control Research Program from seven different departments at Yale University. 23 of the members have NIH/NCI funding to support their research projects. The total cancer-related grant support for the program members in 2010 is just under $15 million.